Additional file 3 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer

MLA

Heidegger, Isabel, et al. Additional File 3 of Comprehensive Characterization of the Prostate Tumor Microenvironment Identifies CXCR4/CXCL12 Crosstalk as a Novel Antiangiogenic Therapeutic Target in Prostate Cancer. Jan. 2022. EBSCOhost, https://doi.org/10.6084/m9.figshare.20098793.

APA

Heidegger, I., Fotakis, G., Offermann, A., Goveia, J., Daum, S., Salcher, S., Noureen, A., Timmer-Bosscha, H., Schäfer, G., Walenkamp, A., Perner, S., Beatovic, A., Moisse, M., Plattner, C., Krogsdam, A., Haybaeck, J., Sopper, S., Thaler, S., Keller, M. A., … Pircher, A. (2022). Additional file 3 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer. https://doi.org/10.6084/m9.figshare.20098793

Chicago

Heidegger, Isabel, Georgios Fotakis, Anne Offermann, Jermaine Goveia, Sophia Daum, Stefan Salcher, Asma Noureen, et al. 2022. “Additional File 3 of Comprehensive Characterization of the Prostate Tumor Microenvironment Identifies CXCR4/CXCL12 Crosstalk as a Novel Antiangiogenic Therapeutic Target in Prostate Cancer,” January. doi:10.6084/m9.figshare.20098793.